Patient Education in Adherence on Acne (PEAce)

NCT ID: NCT02307266

Last Updated: 2021-02-18

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

97 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-11-30

Study Completion Date

2015-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a multi-center, randomised and controlled study in subjects with acne vulgaris. The main objective of this study is to evaluate the effect of a supplementary patient education intervention (in addition to the standard-of-care patient education) on treatment adherence and satisfaction among acne patients receiving once-daily EpiduoTM gel treatment in primary care clinics.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acne

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Standard of care + supplementary education

Subjects will receive supplementary patient educational material in addition to standard-of-care instructions.

Group Type EXPERIMENTAL

Standard of care + supplementary education

Intervention Type BEHAVIORAL

Standard of care

Subjects will receive standard-of-care instructions only.

Group Type EXPERIMENTAL

Standard of care

Intervention Type BEHAVIORAL

Standard of care + additional visits

Subjects will receive standard-of-care instructions, and two additional clinical visits.

Group Type EXPERIMENTAL

Standard of care + additional visits

Intervention Type BEHAVIORAL

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Standard of care + supplementary education

Intervention Type BEHAVIORAL

Standard of care + additional visits

Intervention Type BEHAVIORAL

Standard of care

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Male or female subjects age of 12 years or older,
2. With facial acne vulgaris that can be managed in primary care

Exclusion Criteria

1. Female subjects who are pregnant, nursing or planning a pregnancy during the study,
2. Subjects have a very severe variant of acne such as fulminating acne with systemic symptoms (acne fulminans)
Minimum Eligible Age

12 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Galderma R&D

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Swan Lane Medical Centre

Bolton, , United Kingdom

Site Status

Burbage Surgery

Burbage, , United Kingdom

Site Status

South Axholme Practice

Epworth, , United Kingdom

Site Status

Dr Moss and Partners

Harrogate, , United Kingdom

Site Status

Barlow Medical Centre

Manchester, , United Kingdom

Site Status

Leicester Terrace Health Care Centre

Northampton, , United Kingdom

Site Status

University of Nottingham Health Service

Nottingham, , United Kingdom

Site Status

Rothwell and Desborough Healthcare Group

Rothwell, , United Kingdom

Site Status

Albany House Medical Centre

Wellingborough, , United Kingdom

Site Status

Whitby Group Practice

Whitby, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

References

Explore related publications, articles, or registry entries linked to this study.

Myhill T, Coulson W, Nixon P, Royal S, McCormack T, Kerrouche N. Use of Supplementary Patient Education Material Increases Treatment Adherence and Satisfaction Among Acne Patients Receiving Adapalene 0.1%/Benzoyl Peroxide 2.5% Gel in Primary Care Clinics: A Multicenter, Randomized, Controlled Clinical Study. Dermatol Ther (Heidelb). 2017 Dec;7(4):515-524. doi: 10.1007/s13555-017-0203-4. Epub 2017 Oct 12.

Reference Type DERIVED
PMID: 29027127 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

RD.03.SPR.102710

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Epiduo Pediatric Acne Study
NCT01138735 COMPLETED PHASE4
Experience With Topical Acne Treatment
NCT05582434 ACTIVE_NOT_RECRUITING EARLY_PHASE1